Pharmacy — Supplier News

Camber Pharmaceuticals launches generic Invega

Camber Pharmaceuticals is pleased to announce the addition of paliperidone extended-release tablets to its current portfolio.

, and Bill Schiffner

February 12, 2024 . 11:58 AM

1 min read

PISCATAWAY, N.J. — Camber Pharmaceuticals is pleased to announce the addition of paliperidone extended-release tablets to its current portfolio.Paliperidone extended- release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia, treatment of schizoaffective disorder as monotherapy, and as an adjunct to mood

stabilizers and/or antidepressants.

Paliperidone extended- release tablets are available in 1.5, 3, 6, and 9 mg strengths in 30 count bottles.

Comments

Latest

Pharmacy

Biosimilars Council's Craig Burton testifies before Congress on biosimilars crisis

Regulatory obstacles and anticompetitive abuses threaten patient care; American healthc are system on track to lose $189 billion in patient savings.

, and CDR

April 8, 2025

Pharmacy

Teva and Samsung Bioepis announce Biosimilar EPYSQLI Injection now available in the U.S.

In January 2025, Teva and Samsung Bioepis entered into a strategic partnership for the commercialization of EPYSQLI in the U.S. market.

, and CDR

April 8, 2025

Research

Circana: Consumers shop at 39 unique retailers a year, focusing on convenience and value

This shift highlights an evolving consumer landscape where value, convenience, and occasion-based spending impact buying behavior, according to recent research by Circana.

, and CDR

April 8, 2025

Retail News

NRF: Easter spending to reach $23.6 billion this year

The figure represents a significant increase from last year’s $22.4 billion and comes close to the record-setting $24 billion spent in 2023.

, and Thorvardur de Shong

April 8, 2025

Camber Pharmaceuticals launches generic Invega

Table of Contents

Comments

Related

Latest